Novel methods to prevent HCV transmission - Wikidata - awgldk - TriplyDB

Novel methods to prevent HCV transmission

Novel methods to prevent HCV transmission

http://www.wikidata.org/entity/Q58439383

about

Novel methods to prevent HCV transmission

http://www.wikidata.org/entity/Q58439383

description

article

@en

im September 2017 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2017

@uk

name

Novel methods to prevent HCV transmission

@en

Novel methods to prevent HCV transmission

@nl

type

label

Novel methods to prevent HCV transmission

@en

Novel methods to prevent HCV transmission

@nl

prefLabel

Novel methods to prevent HCV transmission

@en

Novel methods to prevent HCV transmission

@nl

P1433

Q58439383-25E1123F-783A-4924-9F1F-4966FF11C596

P1476

Q58439383-74290DF6-2BE7-4BE4-B64A-C135736F74CC

P2093

Q58439383-9DCB8CA1-8D5B-44C4-A329-F03383422851

P2860

Q58439383-060FAC9E-F8C2-49B6-97C5-AEC89CAC45E6

Q58439383-0B233DA5-0BCF-41BE-96F0-BA07DE259949

Q58439383-13294328-8DDA-403E-9507-61F8AD3938A2

Q58439383-14702B0E-D86E-4A65-9D1C-81EDF83C120F

Q58439383-17C790E5-72E9-4964-9306-72B749EF6EC2

Q58439383-299B3D0A-C61C-46AD-904D-9129BD7BAD92

Q58439383-37269898-DDA8-49D9-ABFA-26D62A7280D2

Q58439383-401CF070-0BC7-42E1-BCBD-27CFBE05B58D

Q58439383-427B4C4E-E897-402E-9CA7-84DAC033D762

Q58439383-48F1FDD2-73CE-4978-ABDE-CC57A128BCAB

P304

Q58439383-2DD64C3A-4E56-4C8D-B944-D520991D380E

P31

Q58439383-DE299C54-31AE-4CF9-A066-E4EA80DBED6E

P356

Q58439383-8C7D8AF1-6595-4819-BB4D-27AD94BC786F

P433

Q58439383-1B764126-AF09-42F0-9B97-FAE3D303A8E6

P478

Q58439383-E6313610-3555-47F6-A1BE-18500CEDE868

P50

Q58439383-4684CF18-CE5E-4299-9304-47680AFC8D84

P577

Q58439383-A9D47906-8830-42E8-8853-7227B23566C2

P356

P1433

Future Virology

P1476

Novel methods to prevent HCV transmission

@en

P2093

Marcus Dorner

http://www.w3.org/2001/XMLSchema#string

P2860

Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge

Hepatitis C virus infection.

Reverse epitope mapping of the E2 glycoprotein in antibody associated hepatitis C virus.

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.

Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus

Broadly neutralizing antibodies abrogate established hepatitis C virus infection

A genetically humanized mouse model for hepatitis C virus infection

Hepatitis C vaccine clinical trials among people who use drugs: potential for participation and involvement in recruitment.

SEC14L2 enables pan-genotype HCV replication in cell culture.

Lessons from Nature: Understanding Immunity to HCV to Guide Vaccine Design.

P304

471-473

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FVL-2017-0072

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Ana Maria Ortega-Prieto

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime